Angiotensin II has been implicated as an important factor in cardiac remodeling, particularly in the development of pathological left ventricular hypertrophy. It is generally assumed that angiotensin II is able to alter the phenotype of cardiac myocytes and fibroblasts, and several experiments have suggested that this peptide can particularly affect the proliferation of cardiac fibroblasts. However, a review of the published results indicates that there is no evidence that angiotensin II can directly trigger mitogenesis through activation of the cyclin-dependent pathway. The observed proliferative effect might well be caused by stimulation of the synthesis of growth or inflammatory substances like platelet-derived growth factor and cytokines, by integrin activation due to secreted extracellular matrix proteins, or by a combination of these mechanisms. Angiotensin II thus appears to differentiate cardiac fibroblasts into a growth substance-secreting phenotype.
Introduction
growth and cause structural alteration of the cardiac interstitium [6] . Increased hemodynamic workload is well known to alter
The disproportionate involvement of the non-myocytes the structure and muscle content of the heart and blood in the accumulation of extracellular matrix (ECM) is not vessels [1, 2] . While this response is sometimes considered univocally accompanied by myocardium hypertrophy [4, 7] . a normal adaptive and defense mechanism to decrease wall In fact, fibrosis often appears in association either with the stress and maintain cardiac function, it may also result hypertrophied left ventricle, as seen with suprarenal aortic under pathological conditions in increased myocardial occlusion and unilateral renal ischemia, or with the hystiffness and ventricular diastolic dysfunction leading to pertrophied right ventricle, as observed in pulmonary chronic heart failure [3] .
arterial banding. On the other hand, fibrosis does not This structural impairment is characterized by two develop in the hypertrophied ventricles following chronic remodeling events: an increment of the myocardial mass volume overload, caused by anemia, compensated arwith or without a disproportionate accumulation of fibrous teriovenous fistula, hyperthyroidism, exercise training and tissue [4] , which involve two major cell types of ventricuatrial septal defect, or pressure overload with infrarenal lar tissue. Cardiomyocytes, forming the contractile comaortic banding. The observed diversity of response in these ponent of the myocardium, become hypertrophied increasmodels indicates that specific stimuli are sometimes ining the cardiac mass. These cells may eventually die by fluencing the growth of cardiomyocytes and fibroblasts and necrosis or apoptosis [5] . The majority of the non-myocyte the development of fibrosis in an independent fashion. interstitial fraction, cardiac fibroblasts, present exaggerated During cardiac remodeling, cardiac fibroblasts can undergo three important, but not necessarily associated, phenotypic changes: (1) they assume a myofibroblast character by expressing smooth muscle a-actin and con-2. In vivo effects of Ang II on cardiac fibroblast taining contractile stress fibers [8] , (2) they proliferate, and proliferation (3) they produce ECM components, including fibronectin, laminin and collagen I and III in the interstitium and
In vivo studies are essential to define the around blood vessels [9] . As a consequence, fibrous pathophysiological role of Ang II. However, there is little material deposition, called reactive fibrosis, alters the proof supporting a direct role of the growth effect of Ang highly organized matrix and the interconnections between II in experimental models of cardiac hypertrophy, comcardiac myocytes and neighboring capillaries, impairing pared to the number of in vitro studies. The main reason myocyte contractility, oxygenation, and metabolism [4] .
for this is that it is almost impossible to generate a model Cardiac myocyte phenotypic changes appear more closewith physiological experimental conditions in which maly related to ventricular loading, while the growth of nipulation of the RAS would not induce a concomitant cardiac fibroblasts appears to be regulated by several change in blood pressure. It is necessary to dissociate autocrine, paracrine, endocrine and mechanical factors indirect effects, such as blood pressure and myocardium [10] [11] [12] . The renin-angiotensin system (RAS) and its stretch, from direct effects of the peptide on cardiac cells peptide product, angiotensin II (Ang II) acting through the in the development of hypertension-induced cardiac hyangiotensin type 1 (AT1) receptor, have emerged as potent pertrophy. Thus, precautions must be taken for correct contributors of cardiac remodeling. Several results from interpretation of the results. Nevertheless, in vivo studies the literature support a potential role of Ang II in cardiac coupled with numerous in vitro findings, reported so far, myocyte and fibroblast growth, ECM protein production represent substantial progress in elaborating the molecular and adhesion to matrix proteins [13] (Fig. 1A) . To date, and cellular mechanisms of Ang II-mediated cardiovascuremodeling has been largely ascribed to proliferation of lar diseases. non-myocytes. However, re-examination of the data indiAng II infusion in rats has been shown to induce cardiac cates that the proliferative effects of Ang II on cardiac hypertrophy via the AT1 receptor independently of its fibroblasts may not be as strong as initially suggested. In blood pressure-elevating effect. Chronic Ang II infusion this review, we will firstly summarize results that were (600-1000 ng / kg per min i.p.) in adult rats induces obtained in whole animals, suggesting that Ang II may myocyte injury and, subsequently, wound healing [14] . In potentially cause proliferation of fibroblasts in the myocarresponse to this injury, there is cardiac fibroblast reparative dium. Secondly, we will review the in vitro experiments proliferation that peaks on day 2 of Ang II infusion, before showing Ang II-induced fibroblast proliferation and disany significant increase in blood pressure. In the same cuss the points that Ang II may not fulfil the criteria of a study, similar results were observed in a rat model of true growth factor. renovascular hypertension, in which endogenous stimula- tion of Ang II production occurred in the ischemic kidney Ang II infusion (1000 ng / kg per min s.c.), extensive by comparison with sham-operated rats or with hypertenproliferation of fibroblasts and fibrosis was observed, sive rats with infrarenal aortic constriction and no renal mostly in areas of the myocardium expressing the AT1 ischemia. The Ang II-stimulated DNA synthesis reflected a receptor. The authors concluded that the effects of Ang II wound-healing process defined as fibroblast proliferation were mediated both by systemic and local actions. The and replacement fibrosis of myocytolysis. Furthermore, in latter effect was mediated by the AT1 receptor on the renovascular hypertension rat model, both myocyte myocytes, implying that communication between cardiac injury and fibroplasia were prevented with captopril, an myocytes and fibroblasts plays an important role in the angiotensin-converting enzyme (ACE) inhibitor, suggestprocess of Ang II-induced cardiac remodeling. ing that Ang II can act directly on cardiac cells. Indeed, Campbell et al. [22] reported temporal changes in myocytolysis-stimulated fibroblast proliferation and colfibroblast proliferation in vivo, using proliferating cell lagen deposition correspond to a reparative process:
nuclear antigen S-phase as a marker of cell proliferation. myocytes are replaced by non-contractile cells [15] .
They demonstrated a direct proliferative effect of Ang II in In another study, chronic infusion of Ang II (520 ng / kg two experimental models where increased circulating Ang per min s.c.) induces at day 3 a significant rise in blood II level was achieved by chronic Ang II infusion (150 pressure together with an acute fibrotic response within the ng / kg per min s.c.) or by unilateral renal ischemia. heart. Ang II stimulates fibronectin, collagen type I and IV Clusters of proliferating cardiac fibroblasts were localized expression in association with the proliferation of interstibetween days 2 and 4 at sites of myocyte necrosis and tial fibroblasts by a direct action that could be prevented by around the vessel walls. In comparison, this study also losartan, an AT1 receptor antagonist [16] .
revealed that chronic aldosterone administration elicited its Sun and Weber [17] showed that ACE was colocalized proliferative response until week 4. The authors concluded in cardiac infarcted scars with myofibroblasts, suggesting that Ang II and aldosterone induce cell proliferation and, that local production of Ang II be involved in tissue repair.
ultimately, fibrosis by separate mechanisms. Interestingly Recently, Higaki et al. [18] reported that in vivo transfecin this study, the myocardium was also infiltrated by tion of a human ACE transgene in the rat myocardium macrophages and lymphocytes in a time course similar to resulted in a significant increase in cardiac ACE activity that of fibroblast proliferation, suggesting that cytokines together with myocyte hypertrophy and increased collagen may also participate in the reparative fibrotic process. content. This indicates that, independently of systemic and
In that context, many in vivo studies reported an hemodynamic factors, autocrine / paracrine Ang II can inflammatory response that operates both systemically and directly cause hypertrophy and fibrosis. In addition, a locally prior to fibroblast proliferation and subsequent growing body of evidence from pharmacological invesperivascular fibrosis that may contribute to myocardial cell tigations and clinical studies on the effects of ACE death and necrosis. This response can be considered as a inhibitors supports the notion that Ang II may act as an defense reaction by the fact that inflammatory cytokines endogenous growth factor for the myocardium. However, attract and activate fibroblasts, stimulate cell growth and ACE inhibitors can also inhibit kinin and bradykinin proliferation and, thus, promote repair and healing. catabolism. Therefore, some effects of these drugs might Myofibroblasts also play an important role in the innot have been solely due to Ang II inhibition [19] . flammatory response, through secretion of cytokines and Ang II may differentially regulate cell proliferation in chemokines, and in wound repair leading to local fibrosis the myocardium. McEvans et al.
[20] assessed 5-bromo-29-through production of ECM proteins such as collagen, deoxy-uridine (BrdU) incorporation in the heart after a glycoaminoglycans, tenascin and fibronectin [23] . In addi-2-week treatment with Ang II infusion (200 ng / kg per tion, Ang II itself can participate in several steps of the min). Concomitantly with a substantial elevation in blood immune and inflammatory responses: it is a potent medipressure, proliferation was increased within medial vascuator of oxidative stress, it stimulates release of cytokines lar smooth muscle cells (VSMC) and in associated adand growth-regulatory factors by mononuclear cells and ventitial / interstitial fibroblasts of intramyocardial coronary regulates the recruitment of proinflammatory cells into the blood vessels of the atria and ventricles. In contrast, site of injury [24, 25] . The inflammatory cells can also proliferation of arteriolar endothelial cell was decreased.
release enzymes, including ACE and chymases, that Concomitant treatment with losartan prevented the Ang generate Ang II thus creating a positive feedback mecha-II-induced fibroblast proliferation, implying participation nism for local Ang II generation. of the AT1 receptor.
In light of the in vivo investigations, the peripheral To further characterize the mode of action of Ang II in effects (elevation of blood pressure) are often a constant of cardiac remodeling, an AT1 receptor chimeric mouse was Ang II infusion. Consequently the mechanical actions of generated by mixing embryonic stem cells harboring or not Ang II can hardly be dissociated from a direct cellular the AT1A receptor gene, utilizing the ROSA26 transgenic mitogenic induction or from indirect growth-promoting mouse strain [21] . In response to a chronic hypertensive secreted substances. Unresolved questions and controver-sies concerning the mechanisms by which Ang II exerts its Either subconfluent or confluent cultures were used. All effects on cardiac fibroblasts still remain.
cultures were first submitted for 24-48 h to a low-serum medium to synchronize the cells in the G phase of the cell 0 cycle. The cells were stimulated with Ang II concentration 28 26 3. In vitro proliferation of cardiac fibroblasts by Ang between 10 and 10 mol / l for a period of 24-48 h. 3 
II: neonatal versus adult cell
[ H]Thymidine incorporation was the most frequently-used assay assessing cell proliferation indirectly. But, as already Several results from the literature, reviewed in the discussed by Boulton and Hodgson [26] , the incorporation previous section, indicate that there is a close relationship of labeled thymidine, although rapid, may not be totally between differentiation and proliferation of mesenchymal specific, and may generate false positive results. Incorporacells in the myocardium and Ang II. They suggest that Ang tion of BrdU, measurement of DNA content and mito-II may act as a potent stimulator of fibroblast proliferation.
chondrial metabolic transformation of 3-(4,5-diHowever, because in vivo experiments do not allow methylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide direct association between a causal agent and its conse-(MTT) will also measure the extent of DNA synthesis or quence, many investigators have turned to in vitro models.
cell viability, which may not perfectly correlate with cell For this purpose, cultures of cardiac fibroblasts were division and thus remain crude proliferative indices. Cell established. These cultures are relatively easy to prepare count is probably the most reliable assay that will present from the myocardium and grow free of contaminating an exact picture of cell division in the dishes, although this cells. Two types of cardiac fibroblast cultures can be technique is more laborious and less sensitive. In most of prepared, either from newborn or from adult animals. In the recorded studies (14 out of 17), Ang II demonstrates its the case of newborn animals, the heart ventricle is dissecability to increase the proliferation of cardiac fibroblasts of ted and digested by a collagenase-trypsin mixture. At this newborn rats, generally by a factor of 20-40% in a period stage of life, cardiac myocytes are still relatively unof 24-48 h. differentiated, compared to their adult counterparts, and are
Fewer proliferation experiments have been carried out fairly resistant to protease digestion. As a consequence, the on adult cardiac fibroblasts (Table 2) . Cultured fibroblasts digested myocardium of neonatal animals mainly contains were generated from 7-to 10-week-old rats and were used a mixture of cardiac myocytes and fibroblasts, along with between the 1st and the 10th passage. Numerous succesadditional cells including VSMC, endothelial cells, neurosive passages of primary cultured cardiac fibroblasts may nal cells and macrophages. A pre-plating step on plastic selectively modify their phenotypes and consequently culture dishes, usually repeated twice, allows the attachaffect their responses. All cultures were deprived of serum ment of fast adhering cells like fibroblasts and enriches the for at least 24 h before stimulation. The fibroblasts were 211 23 non-adherent preparation in cardiac myocytes. Pre-plated incubated with 10 -10 mol / l Ang II for a period cells contain more than 90% neonatal cardiac fibroblasts. If varying from 24 h to 9 days. Four studies out of six could greater purity is needed, it can be obtained by passaging not detect any increase in proliferation as investigated by 3 the cells 1-3 times since cardiac myocytes will not tolerate [ H]thymidine incorporation or cell count. However, the this treatment. The reader is referred to the literature cited state of cell density seems to greatly affect the proliferative in Table 1 for further methodological details.
response of adult fibroblasts to Ang II. In this regard, the During the preparation of cardiac fibroblasts from the article of Simm and Diez [27] is particularly interesting. 21 adult heart, cardiomyocytes, which become Ca -intolerThese authors observed that confluent cultures (above 13 5 2 ant in adulthood, will be lysed by the digestion process. As 10 cells / cm ) of rat adult cardiac fibroblasts did not 27 a consequence, the digestion mixture does not contain any respond at all to 10 mol / l Ang II, whereas proliferation 4 viable cardiomyocytes and is plated directly on plastic can occur with lower density cultures (below 2310 cells / 2 2 culture dishes (1 heart / 1500 cm ). Within 4 days, the cell cm ). However, this positive response took at least 40 h of culture is subconfluent with the cells occupying 60-90% incubation to be recorded. Even more interesting, this of the plastic surface. Under these conditions, the adult growth response can be completely blocked by the addition fibroblast culture is greater than 95% pure. Occasionally, of anti-platelet-derived growth factor (PDGF)-AA antisome isolated islets of endothelial cells or some nerve cells bodies. As concluded by these authors, the Ang II-depencan be observed. As with neonatal cells, one or two dent cell proliferation of adult cardiac fibroblasts was passages can remove any contaminating cells. mainly due to cell density-dependent expression of PDGFThese two cardiac fibroblast culture models have been AA. Cell-cell contact is a characteristic of high density used by several investigators to examine whether or not cultures and contact inhibition may result in failure to Ang II is able to induce cell proliferation. Among the two induce response. models, fibroblast culture from hearts of newborn rats was Cultures of cardiac fibroblasts from adult human and used most often (Table 1) . Usually, rats were 1-3 days rabbit myocardia have also been used to verify the old, and fibroblasts were not passaged more than fourfold.
proliferative action of Ang II. As indicated in Table 3 , all BrdU, 5-bromo-29-deoxy-uridine; ERK, extracellular regulated kinase; ET-1, endothelin-1; MAPK, mitogen-activated protein kinase; PKC, protein kinase C; STAT, signal transducer and activator of transcription; TGF-b1, transforming growth factor-b1. MAPK, mitogen-activated protein kinase; PKC, protein kinase C; SHR, spontaneously hypertensive rat; TGF-b1, transforming growth factor-b1. BrdU, 5-bromo-29-deoxy-uridine; MAPK, mitogen-activated protein kinase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; phos FAK, phosphorylation of focal adhesion kinase; TGF-b1, transforming growth factor-b1. studies, except 1, found that Ang II had a positive induce a growth factor, which will then turn on the cell proliferative effect. In three cases, incubation was longer division machinery, as described by Simm and Diez [27] . than 48 h, suggesting the autocrine / paracrine action of an unidentified growth factor. Mutagenic substances are expected to induce DNA replication within a period shorter than 24 h after their addition [28] . In addition, it must also 4. How different are neonatal from adult cardiac be specified that human and rabbit cardiac fibroblasts seem fibroblasts? to possess an atypical angiotensin receptor that, in some cases, could not be blocked with the AT1 antagonist For reasons of simplicity and reproducibility, the culture losartan and could be stimulated by angiotensin IV [29-of myocytes from newborn rat hearts was, and is still, used 31].
as a model of choice to examine the behavior of these cells The results presented in Table 1 suggest that Ang II under different experimental conditions. Isolation of possesses some mitogenic action and induces proliferation neonatal cardiomyocytes requires two pre-plating steps to of neonatal cardiac fibroblasts mainly through the AT1 remove cardiac fibroblasts. Such fibroblasts thus represent receptor. However, no experiments have been performed a byproduct of cardiomyocyte preparation, and have been on these cells to test whether Ang II can also stimulate the used as a convenient source of cardiac fibroblasts for in synthesis of a proliferative factor that can act through vitro experiments. autocrine / paracrine mechanisms. In contrast, Ang II-inHowever, it is now well-documented that neonatal duced proliferation of adult cardiac fibroblasts seems to be cardiac myocytes are clearly distinct from adult myocytes. more questionable. Although in vivo experiments in adult Neonatal cardiomyocytes represent partially differentiated animal models, with either AT1 antagonists or ACE cells. After birth and within 1-2 weeks, neonatal carinhibitors, suggest a role for Ang II in the growth of these diomyocytes progressively lose the expression of so-called cells, in vitro experiments do not seem to supply evidence 'fetal genes' and adopt an adult phenotype [34] . Accordfor such a role. Ang II can effectively increase the ingly, the response of neonatal cardiac myocytes to any synthesis of pro-fibrotic substances, like collagen and given stimulus may be quite distinct from that of adult transforming growth factor (TGF)-b1, in adult cardiac cells. A typical example is probably the expression of fibroblasts (Table 2) . It can also partially differentiate natriuretic peptides: neonatal ventricular myocytes synthese cells into myofibroblasts as evaluated by an increased thesize and secrete both atrial natriuretic peptide (ANP) synthesis of integrins, actinin, actin and its organization and brain natriuretic peptide (BNP). After birth, the cells into myofilaments [32, 33] . But there is no evidence that rapidly lose this capacity, and adult ventricular myocytes, the peptide has a direct action on the cell cycle. This, under normal conditions, only express a minute amount of however, does not exclude the possibility that Ang II may these two peptides. However, under cardiac failure con-ditions, 'fetal genes', including both natriuretic peptide quiescent state (G ) to mitosis (M) and including DNA 0 genes, are re-expressed at high level [35] . replication (S). Growth factors are able to reintroduce the No direct comparisons have ever been made between cells from the quiescent G phase into the G phase of the 0 1 neonatal and adult cardiac fibroblasts. Although data are cycle up to the restriction point (R) after which cells are lacking, it is conceivable that, considering their environcommitted to enter the S phase with concurrent ment and maturation of the heart after birth, neonatal mitogenesis [28] . Unfortunately at present, no studies have cardiac fibroblasts may differ and respond in a dissimilar examined the activation state of cyclin / cyclin-dependent way than adult cells. kinase pathway after Ang II stimulation in cardiac fibroblasts. Such studies should be conducted under a reasonable time frame (within 24 h) after Ang II addition 5. Ang II augments the synthesis and secretion of to avoid any possible artifacts of secreted growth subautocrine / paracrine substances stances. Lessons from VSCM can certainly be useful in this context. Indeed, Ang II can cause VSCM proliferation, but One plausible reason that may explain why Ang II has through the indirect synthesis of several growth factors been variably reported to increase the proliferation of adult [38, 39] . Further investigations have demonstrated that, in fibroblasts is the secretion of growth substances. Under contrast to PDGF-BB, Ang II was unable to either activate certain experimental conditions (number of passages, cell cellular events of G / S transition [40, 41] or to induce 1 density, length of stimulation), Ang II may or may not formation of the cdc2 / cyclin B complex in S / M transition trigger the synthesis of several factors. Indeed, there are [42] . In addition, recent reports, reviewed by Saito and many examples in the literature demonstrating that Ang II Berck [43] , suggest that a direct transactivation of growth stimulates the secretion of several hormones by cardiac factor tyrosine kinase receptors by Ang II is possible in fibroblasts, as presented in Table 1 : endothelin-1, TGF-b1, VSMC. Whether or not similar patterns of response are and PDGF-AA. Each of these agents can potentially act as possible in cardiac fibroblasts remains to be investigated. a proliferative factor. In addition, Ang II augments the synthesis of extracellular matrix (ECM) proteins, like collagen, fibronectin, laminin and osteopontin, and de-7. Is the cell culture model a good model? creases the secretion of ECM-degrading enzymes, the matrix metalloproteases. In coordination with their respecResults to date may thus suggest that, even in vivo, the tive adhesion receptors, the integrins, ECM proteins can actions of Ang II on the proliferation of fibroblasts in the notably modify the growth behavior of cardiac fibroblasts. myocardium are mediated through autocrine / paracrine In that context, the work of Ashizawa et al. [36] is factors. However, this assertion must be viewed with particularly informative. These authors incubated neonatal caution. Fibroblasts in vivo are in a different environment cardiac fibroblasts in the presence of Ang II. In parallel to than fibroblasts grown on plastic, and may therefore the increase in DNA synthesis, they observed induction of present different behavior. Several parameters in vivo are synthesis and secretion of osteopontin. Osteopontin is an absent from cells grown in an artificial medium. Cells in ECM protein containing an Arg-Gly-Asp (RGD) motif tissue are surrounded by a three-dimensional matrix and and is able to interact with RGD-dependent integrins, like are bathed in an extracellular medium rich in proteins and avb3. Its presence has been associated with vascular hormones. The proximity of other fibroblasts and of other remodeling and restenosis. In that particular experiment, an cell types is difficult to reproduce and experiment in vitro. antibody against osteopontin as well as RGD peptide were Recently, attempts have been made to study the interaction both able to completely block Ang II-stimulated DNA of cardiac fibroblasts embedded in a collagen gel [36] . This synthesis. This indicates that the Ang II proliferative effect may partially reproduce the in vivo three-dimensional was mediated indirectly via integrin binding and activation structure of tissue, and it is expected that fibroblasts will of specific integrin signaling pathways. It is also possible present a different morphology than that observed on that integrins act in concert with growth factor receptors at culture dishes. No experiments have yet been conducted to focal clusters to maximize cell-anchorage-dependent further characterize the proliferative response of these growth, as already described [37] . These results thus fibroblasts to Ang II in a three-dimensional matrix. suggest that, even in neonatal cardiac fibroblasts, the proliferative action of Ang II may not be direct but mediated by other substances (Fig. 1B) .
Conclusion
Results in the literature indicate that Ang II can increase 6. Ang II and the cell cycle DNA synthesis in neonatal cardiac fibroblasts. However, so far, no systematic studies have been performed to Cell division is a complex mechanism that requires determine the magnitude of these effects on the cell cycle passage through different activation phases, from a basal progression compared to those of a true mitogenic factor
